drugset / Trial / NCT00108394
Osteopenia and Renal Osteodystrophy: Evaluation and Management
RandomizedParallel-groupDouble-blindTreatment
Summary
The purpose of this study is to demonstrate whether pamidronate will preserve or increase bone mass in patients with adynamic bone disease, caused by low bone turnover.
Timeline
- Start
- 2002-10
- Primary completion
- —
- Completion
- 2007-09
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Pamidronate | Small molecule | — | Intravenous |